Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 0
No TA breakdown available.
R&D Momentum
30/100
Pipeline Velocity
0/100
Trial Completion Rate
80/100
Pipeline Concentration
100/100
Pipeline Freshness
62/100
Activity
Last 14 days
One-Shot Ovarian Stimulation Protocol: A Pilot Study Investigating the Endocrine Profile
Sex or no Sex: That is the Question. Impact of Coital Sexual Intercourse on the Clinical Pregnancy Rate After Embryo Transfer.
The Impact of Ovarian Stimulation Intensity on Embryo Euploidy in Advanced Age Women
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)